Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Neonmind Biosciences Inc (NEON.CN)

Neonmind Biosciences Inc (NEON.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 17,412
  • Shares Outstanding, K 120,083
  • Annual Sales, $ 416 K
  • Annual Income, $ -2,677 K
  • 60-Month Beta N/A
  • Price/Sales 41.07
  • Price/Cash Flow N/A
  • Price/Book 6.88
Trade NEON.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings -0.03 on 02/28/21
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.130 +15.38%
on 07/20/21
0.170 -11.76%
on 07/07/21
-0.015 (-9.09%)
since 07/02/21
3-Month
0.130 +15.38%
on 07/20/21
0.200 -25.00%
on 05/04/21
-0.050 (-25.00%)
since 05/03/21

Most Recent Stories

More News
Stocks in play: NeonMind Biosciences Inc.

Announced today the appointment of Dr. Sagar Parikh, MD to its Specialty Clinics Advisory Board. In ...

NEON.CN : 0.150 (+3.45%)
Psilocybin May Be the Key to Resolving the Global Obesity Epidemic

The global obesity issue is bursting at the seams. According to the World Health Organization, obesity ...

CLXPF : 3.0300 (-4.72%)
MMEDF : 4.6900 (+33.24%)
CMPS : 33.20 (-2.18%)
NMDBF : 0.1150 (-4.09%)
TRYP.CN : 0.650 (+12.07%)
NEON.CN : 0.150 (+3.45%)
Dr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory Board

VANCOUVER, BC / ACCESSWIRE / July 28, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on the...

NEON.CN : 0.150 (+3.45%)
NMDBF : 0.1150 (-4.09%)
Stocks in play: NeonMind Biosciences Inc.

NeonMind Biosciences Inc. (CSE:NEON)(OTQBC:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated ...

NMDBF : 0.1150 (-4.09%)
NEON.CN : 0.150 (+3.45%)
This Drug Could Soon Help Millions Battling the Obesity Epidemic

The obesity epidemic in the U.S. is only getting worse. In fact, by the time 2030 rolls around, nearly ...

NMDBF : 0.1150 (-4.09%)
ATAI : 15.39 (-1.60%)
MNMD : 3.01 (-1.95%)
COPHF : 0.0930 (+1.09%)
PHRRF : 0.8300 (-1.19%)
PHRM.CN : 1.040 (-2.80%)
NEON.CN : 0.150 (+3.45%)
NeonMind Provides Integrated Drug Development Plan Update for NEO-001 to Treat Obesity

Target Product Profile and Clinical Phase 1/2 Study Aim To Address Deficiencies In Chronic Weight ManagementPre-IND Meeting in the U.S. and Pre-CTA Consultation Meeting in Canada Targeted for 4Q2021Initiation...

NEON.CN : 0.150 (+3.45%)
NMDBF : 0.1150 (-4.09%)
Stocks in play: NeonMind Biosciences Inc.

Announced that it has launched its NeonMind branded functional mushroom coffee products as dietary supplements ...

NEON.CN : 0.150 (+3.45%)
Healthy Living: Here’s What’s Driving the Mushroom Boom

Mushrooms seem to be popping up everywhere these days. All as millions digest the idea that mushrooms ...

ATAI : 15.39 (-1.60%)
CMPS : 33.20 (-2.18%)
MYCOF : 0.3738 (-5.37%)
CLXPF : 3.0300 (-4.72%)
NMDBF : 0.1150 (-4.09%)
NEON.CN : 0.150 (+3.45%)
NeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the US

VANCOUVER, BC / ACCESSWIRE / June 29, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), a psychedelic drug development company, is pleased to announce that...

NEON.CN : 0.150 (+3.45%)
NMDBF : 0.1150 (-4.09%)
NeonMind to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference

Vancouver, British Columbia--(Newsfile Corp. - June 14, 2021) - () () () ("" or the ""), an integrated drug development and wellness company focused on the potential therapeutic uses of psilocybin for...

NMDBF : 0.1150 (-4.09%)
NEON.CN : 0.150 (+3.45%)

Key Turning Points

3rd Resistance Point 0.153
2nd Resistance Point 0.152
1st Resistance Point 0.148
Last Price 0.150
1st Support Level 0.143
2nd Support Level 0.142
3rd Support Level 0.138

See More

52-Week High 0.350
Fibonacci 61.8% 0.266
Fibonacci 50% 0.240
Fibonacci 38.2% 0.214
Last Price 0.150
52-Week Low 0.130

See More

Business Summary

NeonMind Biosciences Inc manufactures Medicinal Mushroom products under the brand NeonMind which are for sale through e-commerce on its website. It is also in the early stages of development of a product with the goal of using such product to promote and cause weight loss using a compound found in psychedelic...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar